Events
Elahe Rahimian: A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML
We are excited to announce that Elahe Rahimian, Alexander Wurm Group, will defend her PhD thesis:
A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML